Saturday 17 October 2026
Export NRSN’s income statement to Excel — free account
NeuroSense Therapeutics Ltd.
NRSN Healthcare Biotechnology
Insiders bought in the last twelve months.
3.07
0.10
−3.15%
Follow NRSN
| Older periods | Jun '24 | Sep '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
0.00% | 0.00% | 0.00% | 0.00% | |
| 0.00% | 0.00% | 0.00% | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | — | 0.00 | — | |
Free Cash Flow |
(6.87) | — | (10.51) | — | |
Capital Expenditures |
(0.07) | — | (0.06) | — | |
| Other line items | |||||
Cash ROIC |
1,621.46% | 0.00% | (5,530.53%) | 0.00% | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
— | — | 0.00% | — | |
Operating CF/Net income |
0.00 | — | 0.00 | — | |
Depreciation/Fixed assets |
0.18 | 0.00 | 0.35 | 0.00 | |
Capex/Depreciation |
(5.36) | — | (2.86) | — | |
Operating CF per Share |
0.00 | — | 0.00 | — | |
Capex per Share |
0.00 | — | 0.00 | — | |
Capex to Sales |
0.00 | — | 0.00 | — |
Columns are period end dates · fundamentals updated 2 Oct 2026